Invokana Tablet, Film Coated
Product Images NDC 50458-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Invokana (NDC 50458-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Invokana 01)

FDA Label Image

Figure 1 (Invokana 02)

FDA Label Image

Figure 2 (Invokana 03)

FDA Label Image

Figure 3 (Invokana 04)

FDA Label Image

Figure 4 (Invokana 05)

Figure 4 (Invokana 05)
This appears to be a statistical table that compares the number of events experienced by subjects using Canvas and Placebo over a period of weeks. There are also confidence interval values provided. However, it is difficult to provide a more detailed description or interpretation without additional context or information.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (300 mg Tablet Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.